{"nct_id":"NCT04893811","title":"Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of Age","status":"COMPLETED","status_verified_date":"2024-10","start_date":"2021-08-18","start_date_type":"ACTUAL","primary_completion_date":"2023-09-06","primary_completion_date_type":"ACTUAL","completion_date":"2023-09-06","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["PFE"]}